Your browser doesn't support javascript.
loading
Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Martin, Miguel; Press, Michael; Mackey, John; Glaspy, John; Chan, Arlene; Pawlicki, Marek; Pinter, Tamas; Valero, Vicente; Liu, Mei-Ching; Sauter, Guido; von Minckwitz, Gunter; Visco, Frances; Bee, Valerie; Buyse, Marc; Bendahmane, Belguendouz; Tabah-Fisch, Isabelle; Lindsay, Mary-Ann; Riva, Alessandro; Crown, John.
Affiliation
  • Slamon D; Jonsson Comprehensive Cancer Center, University of California­Los Angeles, Los Angeles, CA 90095-1678, USA. dslamon@mednet.ucla.edu
N Engl J Med ; 365(14): 1273-83, 2011 Oct 06.
Article in En | MEDLINE | ID: mdl-21991949
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 / Antibodies, Monoclonal Type of study: Clinical_trials / Guideline Limits: Female / Humans / Middle aged Language: En Journal: N Engl J Med Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 / Antibodies, Monoclonal Type of study: Clinical_trials / Guideline Limits: Female / Humans / Middle aged Language: En Journal: N Engl J Med Year: 2011 Document type: Article Affiliation country: Country of publication: